Catalysts for $TGTX
8 tracked
Nov 2, 2026
earnings
TG THERAPEUTICS, INC. earnings
TG THERAPEUTICS, INC.
→
May 6, 2026
earnings
TG THERAPEUTICS, INC. earnings
TG THERAPEUTICS, INC.
→
Jan 16, 2026
approval
BRIUMVI (UBLITUXIMAB-XIIY) — FDA approval
ublituximab
→
Dec 12, 2025
approval
LEROCHOL (LERODALCIBEP-LIGA) — FDA approval
lerodalcibep
→
Aug 18, 2025
approval
BRIUMVI (UBLITUXIMAB-XIIY) — FDA approval
ublituximab
→
Aug 18, 2025
approval
BRIUMVI (UBLITUXIMAB-XIIY) — FDA approval
ublituximab
→
Oct 30, 2024
approval
BRIUMVI (UBLITUXIMAB-XIIY) — FDA approval
ublituximab
→
Dec 28, 2022
approval
BRIUMVI (UBLITUXIMAB-XIIY) — FDA approval
ublituximab
→